APA (7th ed.) Citation

Azuma, R., Saeki, M., Yamamoto, Y., Hagiwara, Y., Grochow, L. B., & Donehower, R. C. (2002). Metabolism and urinary excretion of a new quinoline anticancer drug, TAS-103, in humans. Xenobiotica, 32(1), 63. https://doi.org/10.1080/00498250110085818

Chicago Style (17th ed.) Citation

Azuma, R., M. Saeki, Y. Yamamoto, Y. Hagiwara, L. B. Grochow, and R. C. Donehower. "Metabolism and Urinary Excretion of a New Quinoline Anticancer Drug, TAS-103, in Humans." Xenobiotica 32, no. 1 (2002): 63. https://doi.org/10.1080/00498250110085818.

MLA (9th ed.) Citation

Azuma, R., et al. "Metabolism and Urinary Excretion of a New Quinoline Anticancer Drug, TAS-103, in Humans." Xenobiotica, vol. 32, no. 1, 2002, p. 63, https://doi.org/10.1080/00498250110085818.